definiens: means that ( a ) it is reasonably anticipated that the entity resulting from a Change of Control ofAstraZeneca, Parent or any Local Affiliate will be unable to perform its obligations in accordance with the terms ofthis Agreement, as reasonably determined based on objective criteria available to both Parties, including the newentity ’s financial position and product pipeline, ( b ) the acquiring entity in such Change of Control or any of itsAffiliates ( prior to the Change of Control ) is actively developing or commercializing a GC - C Agonist indicated forthe treatment of IBS - C, CC, or OIC ( unless as to any such indication, the JDC has determined not to pursueDevelopment for such indication ) or any other indication for which the Product is then being Developed orCommercialized in the Territory pursuant to this Agreement, unless such entity or such Affiliate ceases such activityor [ * * ]